An interventional study of phaco+MP-TSCPC and phaco+TSCPC in Angle Closure Glaucoma, sponsored by Cairo University. Active, not recruiting at 1 site in Egypt. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-08-30.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
comparing different types of cuclophotocoagulation with cataract extraction to cataract extraction and goniocynechiolysis in cases of chronic angle closure glaucoma
Evaluation of the safety of MP-TSCPC , CW-TSCPC and endoscopic cyclophotocoagulation when combined with phacoemulsification in cases with CACG Comparing the efficacy of the combined procedures in control of the IOP and the success rate versus lens extraction combined with synechiolysis
91 studies on the registry are indexed under Glaucoma, Angle-Closure; 17 are open to participants now.
This study's planned enrollment of 88 is above the median of 57 across 58 interventional studies indexed under Glaucoma, Angle-Closure.
Browse Glaucoma, Angle-Closure studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
chronic angle closure glaucoma
Exclusion Criteria:
22 patients with primary angle closure glaucoma will undergo phacoemulsification and micropulse cyclophotocoagulation
Procedure: phaco+MP-TSCPC
22 patients with primary angle closure glaucoma will undergo phaco and transscleral cyclophotocoagulation
Procedure: phaco+TSCPC
22 patients with primary angle closure glaucoma will undergo phaco and endocyclophotocoagulation after cataract removal
Procedure: phaco+endocyclophotocoagulation
22 patients with primary angle closure glaucoma will undergo phaco and goniosynechiolysis
Procedure: phaco GSL
The procedure starts with performing the cyclophotocoagulation using the Micropulse P3 device (IQ 810 Laser Systems; Iridex, Mountain View, CA, USA) at 2500 mW with a duration of 90 seconds in each hemisphere at a 31.3% duty cycle under local anesthesia and then performing phacoemulsification and IOL implantation.
The procedure starts with performing the cyclophotocoagulation using the IRIDEX's G probe device (IRIDEX Corp. Mountain View, CA, USA) at 1500 to2000 mW with a duration of 1500 ms applying about 15 shots in one hemisphere only under local anesthesia and then performing phacoemulsification and IOL implantation.
phacoemulsification will be done and endocyclophotocoagulation will be done after cataract extraction
phacoemulsification will be done and then the angle is visualized by direct goniolens then the synechia are dissected by cohesive viscoelastic.
the percentage of intraocular pressure change
measuring the intraocular pressure after 1M, 3M and 6M
Time frame: 6 Months
percent change of antiglaucoma medications
the number of medication before and after the procedure
Time frame: 6 Months
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.